Revue de presse #6 ACLS, POCUS et la COVID-19

Voici les articles que l’on a trouvé intéressants dernièrement sur les nouvelles recommandations en ACLS, l’échographie au chevet & la prévention des effets indésirables rénaux et la COVID-19

• Article sur les nouvelles recommandations en ACLS
  • Berg KM, Soar J, Andersen LW, Böttiger BW et al. Adult Advanced Life Support: International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science With Treatment Recommendations. Resuscitation. 2020 Sep 21:S0300-9572(20)30460-3. doi: 10.1016/j.resuscitation.2020.09.012. Epub ahead of print. PMID: 33098922.
• Article sur l’utilisation du Doppler veineux sur la prédiction des effets indésirables rénaux
  • Spiegel R, Teeter W, Sullivan S, Tupchong K, Mohammed N, Sutherland M, Leibner E, Rola P, Galvagno SM Jr, Murthi SB. The use of venous Doppler to predict adverse kidney events in a general ICU cohort. Crit Care. 2020 Oct 19;24(1):615. doi: 10.1186/s13054-020-03330-6. PMID: 33076961.

COVID-19

• Article intéressant résumant les cibles thérapeutiques potentielles
  • Shamim S, Khan M, Kharaba ZJ, Ijaz M, Murtaza G. Potential strategies for combating COVID-19. Arch Virol. 2020 Nov;165(11):2419-2438. doi: 10.1007/s00705-020-04768-3. Epub 2020 Aug 10. PMID: 32778950; PMCID: PMC7416802.
• Article intéressant résumant la pathophysiologie, les traitements et le devenir clinique
  • Pinney SP, Giustino G, Halperin JL, Mechanick JI, Neibart E, Olin JW, Rosenson RS, Fuster V. Coronavirus Historical Perspective, Disease Mechanisms, and Clinical Outcomes: JACC Focus Seminar. J Am Coll Cardiol. 2020 Oct 27;76(17):1999-2010. doi: 10.1016/j.jacc.2020.08.058. PMID: 33092736; PMCID: PMC7571970.
• Ça brasse pour le Tocilizumab !
  • Éditorial résumant les plus récentes études
    • Parr JB. Time to Reassess Tocilizumab’s Role in COVID-19 Pneumonia. JAMA Intern Med. 2020 Oct 20. doi: 10.1001/jamainternmed.2020.6557. Epub ahead of print. PMID: 33079980. 
  • Les plus récentes études
    • Étude RCT-TCZ-COVID-19 sur le Tocilizumab
      • Salvarani C, Dolci G, Massari M; RCT-TCZ-COVID-19 Study Group. Effect of Tocilizumab vs Standard Care on Clinical Worsening in Patients Hospitalized With COVID-19 Pneumonia: A Randomized Clinical Trial. JAMA Intern Med. 2020 Oct 20. doi: 10.1001/jamainternmed.2020.6615. Epub ahead of print. PMID: 33080005.
    • Étude CORIMUNO-19 sur le Tocilizumab
      • Hermine  O, Mariette  X, Tharaux  P-L, Resche-Rigon  M, Porcher  R, Ravaud  P; for the CORIMUNO-19 Collaborative Group.  Effect of tocilizumab vs usual care in adults hospitalized with COVID-19 and moderate or severe pneumonia: a randomized clinical trial.   JAMA Intern Med. Published online October 20, 2020. doi:10.1001/jamainternmed.2020.6820
    • Étude STOP-COVID sur le Tocilizumab
      • Gupta S, Wang W, Hayek SS, Chan L; STOP-COVID Investigators. Association Between Early Treatment With Tocilizumab and Mortality Among Critically Ill Patients With COVID-19. JAMA Intern Med. 2020 Oct 20. doi: 10.1001/jamainternmed.2020.6252. Epub ahead of print. PMID: 33080002.

Avez-vous un article à nous suggérer ? Laissez nous savoir !

Commentaires